» Articles » PMID: 34026577

Epidemiological Link Between Obesity, Type 2 Diabetes Mellitus and Cancer

Overview
Specialty General Medicine
Date 2021 May 24
PMID 34026577
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

There exists a complex interaction between obesity, type 2 diabetes mellitus (T2DM) and cancer, and an increase in the incidence of cancer is expected with the growing obesity-diabetes pandemic. The association of cancer with diabetes mellitus and obesity appears to be site-specific, the highest risk being for post-menopausal breast cancer, endometrial cancer, and colorectal cancer. Moreover, there is worsening of hyperglycaemia with the onset of cancer, evidencing a bi-directional link between cancer and diabetes mellitus and the need for monitoring for diabetes in cancer survivors. In this review, we look at the epidemiological evidence from observational studies and Mendelian randomization studies linking obesity, diabetes, and cancer, as well as the complex pathophysiological mechanisms involved, including insulin resistance with associated hyperinsulinaemia, the effect of chronic low-grade inflammation, and the effect of various adipokines that are associated with obesity and T2DM. Additionally, we describe the novel therapeutic strategies, based on their role on the discrete pathophysiological mechanisms involved in the tumourigenesis.

Citing Articles

[Causal Relationship Between Components of Metabolic Syndrome and Endometrial Carcinoma].

Yang M, Hu Y, Guo W, Yang F, Qi X, Zheng Y Sichuan Da Xue Xue Bao Yi Xue Ban. 2025; 55(6):1557-1566.

PMID: 39990839 PMC: 11839343. DOI: 10.12182/20241160109.


Brain Metastasis in Endometrial Cancer: A Systematic Review.

Sambataro D, Gebbia V, Bonasera A, Quattrocchi A, Caputo G, Vinci E Cancers (Basel). 2025; 17(3).

PMID: 39941769 PMC: 11816136. DOI: 10.3390/cancers17030402.


The risk of cancer among insulin glargine users in Lithuania: A retrospective population-based study.

Jonusas J, Drevinskaite M, Linkeviciute-Ulinskiene D, Ladukas A, Patasius A, Zabuliene L Open Med (Wars). 2024; 19(1):20241017.

PMID: 39434861 PMC: 11491771. DOI: 10.1515/med-2024-1017.


Deciphering the Potentials of Cardamom in Cancer Prevention and Therapy: From Kitchen to Clinic.

Bano S, Majumder A, Srivastava A, Nayak K Biomolecules. 2024; 14(9).

PMID: 39334932 PMC: 11430645. DOI: 10.3390/biom14091166.


Impact of Breast Cancer on Cardiometabolic Health in Spanish Women ≥50 Years with Pre-Existing Type 2 Diabetes Mellitus.

Fernandez-Arce L, Robles-Rodriguez N, Fernandez-Feito A, Fernandez-Iglesias R, Del Mar Fernandez-Alvarez M, Lana A Cancers (Basel). 2024; 16(16).

PMID: 39199624 PMC: 11352853. DOI: 10.3390/cancers16162853.


References
1.
Almazeedi S, El-Abd R, Al-Khamis A, Albatineh A, Al-Sabah S . Role of bariatric surgery in reducing the risk of colorectal cancer: a meta-analysis. Br J Surg. 2020; 107(4):348-354. DOI: 10.1002/bjs.11494. View

2.
Senatorov I, Moniri N . The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines. Biochem Pharmacol. 2018; 150:170-180. PMC: 5866782. DOI: 10.1016/j.bcp.2018.02.011. View

3.
Zhang K, Luo Y, Dai H, Deng Z . Effects of Bariatric Surgery on Cancer Risk: Evidence from Meta-analysis. Obes Surg. 2019; 30(4):1265-1272. DOI: 10.1007/s11695-019-04368-4. View

4.
Amano S, Cohen J, Vangala P, Tencerova M, Nicoloro S, Yawe J . Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metab. 2013; 19(1):162-171. PMC: 3931314. DOI: 10.1016/j.cmet.2013.11.017. View

5.
Kim M, Huang Y, Park J . Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views. Cancers (Basel). 2020; 12(12). PMC: 7761926. DOI: 10.3390/cancers12123638. View